FDA — authorised 12 April 1956
- Application: NDA010392
- Marketing authorisation holder: PFIZER
- Local brand name: ATARAX
- Indication: TABLET — ORAL
- Status: approved
FDA authorised Hydroxyzine HCL on 12 April 1956
Yes. FDA authorised it on 12 April 1956.
PFIZER holds the US marketing authorisation.